Mylan to provide EpiPen cost assistance as CEO is asked to testify on price hike; Guardian, 8/25/16

Jana Kasperkevic, Guardian; Mylan to provide EpiPen cost assistance as CEO is asked to testify on price hike:

"Even as Mylan takes steps to make its EpiPen more affordable, lawmakers have called on Bersch to appear before US Congress and explain why the price of EpiPen went up by 461% since Mylan acquired it in 2007.

“We are concerned that these drastic price increases could have a serious effect on the health and well-being of every day Americans,” senators Susan Collins and Claire McCaskill told Bresch in a letter. “As leaders of the Senate Special Committee on Aging, we are particularly concerned that seniors have access to EpiPen because, according to Mylan’s website, older Americans ‘may be at an increased risk of having a more severe anaphylactic reaction if they are exposed to biting and stinging insects’.”

They requested that Bresch testify within the next two weeks.

Even as Mylan was announcing the steps that it is taking to make its EpiPen more affordable, Sarah Jessica Parker issued a statement announcing that she had terminated her relationship with the company. Earlier this year, the Sex and the City actress served as a spokesperson for Mylan, helping raise awareness about anaphylaxis and life-threatening allergies."